Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bio-Techne Corporation (TECH) Profit Margins

Over the twelve months to 2026-06-30, Bio-Techne Corporation (TECH) had gross margin 65.8%, operating margin 20.7%, net margin 15.0%, free cash flow margin 21.7%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TECHBio-Techne CorporationFollow TECH — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
11.4B
P/E TTM
63.1
Dividend yield
0.4%
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2011
Jun 11		FY2012
Jun 12		FY2013
Jun 13		FY2014
Jun 14		FY2015
Jun 15		FY2016
Jun 16		FY2017
Jun 17		FY2018
Jun 18		FY2019
Jun 19		FY2020
Jun 20		FY2021
Jun 21		FY2022
Jun 22		FY2023
Jun 23		FY2024
Jun 24		FY2025
Jun 25		FY2026
Jun 26		TTM
Jun 26		Trend
Gross margin77.6%75.0%74.4%70.3%67.9%67.5%66.5%67.2%66.3%65.4%68.0%68.4%67.7%66.4%64.8%65.8%65.8%
Operating margin56.2%52.8%0.1%44.7%32.5%30.2%21.4%21.2%20.5%21.3%25.5%26.8%26.3%17.8%8.4%20.7%20.7%
Net margin38.7%35.7%36.2%31.0%23.8%20.9%13.5%19.6%13.5%31.0%15.1%24.6%25.1%14.5%6.0%15.0%15.0%
FCF margin42.6%38.4%32.6%34.4%26.4%25.5%22.8%23.2%21.9%20.8%33.1%25.4%19.0%20.4%21.0%21.7%21.7%

USD billions · SEC XBRL

Bio-Techne Corporation — questions

What is Bio-Techne Corporation's gross margin?
65.8% over the twelve months to 2026-06-30.
What is Bio-Techne Corporation's operating margin?
20.7% over the twelve months to 2026-06-30.
What is Bio-Techne Corporation's net profit margin?
15.0% over the twelve months to 2026-06-30.

Every figure on this page comes from Bio-Techne Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.